ASC
MED icon

Atalanta Sosnoff Capital’s Medifast MED Stock Holding History

Atalanta Sosnoff Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,584
Closed -$493K – 100
2023
Q3 		$493K Sell
6,584
-50
-0.8% -$4.44K 0.01% 78
2023
Q2 		$611K Sell
6,634
-58
-0.9% -$5.16K 0.02% 79
2023
Q1 		$694K Buy
+6,692
New +$742K 0.02% 81

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Atalanta Sosnoff Capital's MED Position: Q4 2023 in Review

Atalanta Sosnoff Capital sold out of Medifast (MED) in Q4 2023, closing a stake of 6,584 shares — an estimated $493K sold.

Atalanta Sosnoff Capital first reported a position in MED in Q1 2023 and held it in 3 quarters. The position peaked at $694K in Q1 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Atalanta Sosnoff Capital reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Atalanta Sosnoff Capital sold 6,584 Medifast shares in Q4 2023, an estimated $493K.
  • Atalanta Sosnoff Capital first reported a position in Medifast in Q1 2023 and held it in 3 quarters.
  • Atalanta Sosnoff Capital's Medifast position peaked at $694K in Q1 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Atalanta Sosnoff Capital's 13F filing for Q4 2023, filed 12 Feb 2024.